These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3519402)

  • 1. [Comparison of a semisynthetic human insulin and swine insulin].
    Sailer D; Volkholz HJ; Kolb S; Pichl J
    Fortschr Med; 1986 Apr; 104(16):340-2. PubMed ID: 3519402
    [No Abstract]   [Full Text] [Related]  

  • 2. Human (semisynthetic) insulin and porcine insulin in the treatment of non-insulin-dependent diabetes. A double-blind, comparative clinical trial.
    Moffitt PS; Colagiuri S; Miller JJ; Hall CA
    Med J Aust; 1984 Feb; 140(4):200-2. PubMed ID: 6363896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin.
    Storms GE; Lutterman JA; van 't Laar A
    Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus].
    Sacchetti C; Foco A; David O; Balboni R; Gargano P; Cerutti F; Baratono S
    Minerva Pediatr; 1989 May; 41(5):221-2. PubMed ID: 2677642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of twice daily regimens of Actrapid and Monotard insulins.
    Akintewe TA
    East Afr Med J; 1985 Mar; 62(3):196-9. PubMed ID: 3893969
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled study of prolonged study with semi-synthetic human insulin.
    Drury R; Keenan P; McEvoy M; Cregan D; Drury MI; Reeves WG
    Ir J Med Sci; 1983 Dec; 152(12):430-4. PubMed ID: 6365832
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of fully synthetic human insulin in comparison to porcine insulin in normal subjects.
    Schlüter KJ; Petersen KG; Borsche A; Hobitz H; Kerp L
    Horm Metab Res; 1982 Mar; 14(3):109-11. PubMed ID: 7040195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative study of intensive conventional insulin treatment and a multiple insulin-injection regimen with NovoPen].
    Ditzel J; Clemmensen NK
    Ugeskr Laeger; 1987 May; 149(20):1335-8. PubMed ID: 3299948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological activity of semisynthetic human insulin in healthy persons and in patients with diabetes mellitus].
    Czyzyk A; Rogala H; Stepka M; Krzymień J; Szymerska E
    Pol Arch Med Wewn; 1986 Sep; 76(3):144-51. PubMed ID: 3554161
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood glucose lowering by human insulins and highly purified porcine insulin. Metabolic study in insulin-injecting diabetics].
    Sailer D; Volkholz HJ; Pichl J
    Fortschr Med; 1985 May; 103(19):527-30. PubMed ID: 3891564
    [No Abstract]   [Full Text] [Related]  

  • 15. Human insulin.
    Dardick L; Rodney WM; Sakiyama R
    Am Fam Physician; 1984 Jun; 29(6):204-6. PubMed ID: 6375328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Semisynthetic human insulin in the treatment of diabetes type I. Preliminary experience].
    Vitacolonna E; Consoli A; Capani F
    Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1849-52. PubMed ID: 6394033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The U.S. "new patient" and "transfer" studies.
    Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J
    Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).
    Fineberg SE; Galloway JA; Fineberg NS; Rathbun MJ
    Diabetes Care; 1982; 5 Suppl 2():107-13. PubMed ID: 6765519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.